Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Viral infections

First UK case of monkeypox identified

An individual with the first case of monkeypox in the UK is being treated at Royal Free Hospital in London; however, Public Health England has stated that the risk of transmission to the general population is very low.

The first UK case of monkeypox, a rare viral infection, has been confirmed by Public Health England (PHE).

Monkeypox is a mild self-limiting illness causing symptoms such as fever, headache, muscle aches, swollen lymph nodes, exhaustion and, in some cases, a rash. Most people recover within a few weeks; however, severe illness can occur in some individuals.

According to PHE, infection can be spread when someone is in close contact with an infected person, but it assures that there is a very low risk of transmission to the general population.

The affected individual, who is a resident of Nigeria, is believed to have contracted the infection before coming to the UK. They have been transferred to the expert infectious disease unit at the Royal Free Hospital in London and are receiving appropriate care.

As a precautionary measure, PHE is working closely with NHS colleagues and will be contacting people who might have been in close contact with the individual, including those who were on the same flight to the UK, to provide information and health advice.

“It is important to emphasise that monkeypox does not spread easily between people and the overall risk to the general public is very low,” said Nick Phin, deputy director of the National Infection Service at PHE.

“PHE and the NHS have well-established and robust infection control procedures for dealing with cases of imported infectious disease and these will be strictly followed to minimise the risk of transmission.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205431

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.